Skip to main content
. Author manuscript; available in PMC: 2011 Nov 15.
Published in final edited form as: Mov Disord. 2010 Nov 15;25(15):2516–2523. doi: 10.1002/mds.23393

Table 3.

Regional PIB binding potentials and MCBP.

HC PD-noCI PD-MCI PDD DLB
n 9 8 9 15 6
Occipital 0.14 (0.08) 0.10 (0.09) 0.14 (0.19) 0.08 (0.09) 0.08 (0.06)
Prefrontal* 0.08 (0.18) 0.05 (0.18) 0.05 (0.24) 0.11 (0.27) 0.18 (0.32)
Gyrus Rectus* 0.00 (0.10) 0.00 (0.11) 0.00 (0.20) 0.08 (0.25) 0.16 (0.27)
Temporal* 0.08 (0.11) 0.03 (0.12) 0.05 (0.18) 0.10 (0.19) 0.17 (0.21)
Precuneus* 0.15 (0.13) 0.09 (0.17) 0.22 (0.25) 0.17 (0.28) 0.21 (0.28)
Caudate −0.08 (0.11) −0.05 (0.19) −0.08 (0.13) −0.00 (0.18) 0.02 (0.22)
MCBP 0.08 (0.13) 0.04 (0.14) 0.08 (0.21) 0.11 (0.24) 0.18 (0.26)

Binding potentials are shown as mean (SD). Cortical regions included in MCBP calculation are indicated with an asterisk (*).

PIB = Pittsburgh Compound B; MCBP = mean cortical binding potential; HC = healthy control; PD-noCI = Parkinson disease without cognitive impairment; PD-MCI = Parkinson disease with mild cognitive impairment; PDD = Parkinson disease with dementia; DLB = Dementia with Lewy bodies.